Moberg Pharma AB (publ) (MBGPF)

Moberg Pharma AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-251.38	-255.11	-21.09	-15.71	7.49	5.87
Depreciation & Amortization	301.35	301.32	2.1	2.58	2.58	2.52
Other Amortization	0.04	-	-	-	-	-
Stock-Based Compensation	5.52	4.72	2.31	1.46	0.63	0.95
Other Operating Activities	-65.35	-65.36	-4.36	-3.8	-27.46	2.79
Change in Accounts Receivable	-3.12	-0.71	0.42	-0.21	6.84	-2.79
Change in Inventory	0.66	2.82	-7.12	-	-	-
Change in Other Net Operating Assets	-9.11	-4.14	-5.46	-1.16	-4.99	-18.43
Operating Cash Flow	-21.4	-16.47	-33.21	-16.84	-15.3	-10.41
Cash Acquisitions	-	-	-	-	-10	-2.51
Sale (Purchase) of Intangibles	-71.02	-73.55	-124.12	-68.07	-31.31	-41.42
Investing Cash Flow	-71.02	-73.55	-124.12	-68.07	-41.31	-43.93
Long-Term Debt Repaid	-	-1.39	-2.43	-1.87	-3.46	-
Total Debt Repaid	-1.47	-1.39	-2.43	-1.87	-3.46	-18.17
Net Debt Issued (Repaid)	-1.47	-1.39	-2.43	-1.87	-3.46	-18.17
Issuance of Common Stock	335.52	335.52	100.64	109.68	133.44	37.54
Repurchase of Common Stock	-	-	-0.19	-	-	-558.27
Other Financing Activities	-11.38	-11.38	-5.7	-	-	-
Financing Cash Flow	322.68	322.76	92.33	107.81	129.97	-538.89
Net Cash Flow	230.26	232.73	-65	22.9	73.37	-593.23
Free Cash Flow	-21.4	-16.47	-33.21	-16.84	-15.3	-10.41
Free Cash Flow Margin	-166.39%	-167.87%	-	-8136.23%	-	-30.93%
Free Cash Flow Per Share	-0.50	-0.43	-2.09	-2.22	-3.55	-5.50
Cash Interest Paid	0.23	0.23	0.26	0.07	0.24	2.07
Levered Free Cash Flow	22.9	27.25	-149.44	-65.28	40.32	-
Unlevered Free Cash Flow	23.03	27.4	-149.28	-65.24	40.4	-
Change in Net Working Capital	12.16	2.03	12.13	-11.62	-80.83	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.